September 25, 2016 2:42 AM ET

Biotechnology

Company Overview of ScarX Therapeutics Inc.

Company Overview

ScarX Therapeutics Inc., a biotechnology company, discovers and develops treatments for dermal scarring (fibrosis). It develops SCX-001, a topical prescription cream to treat and prevent post-surgical scarring; and Nefopam active drug substance in SCX-001, a small molecule that inhibits the production of catenin, the protein associated with hypertrophic (excessive) scarring in animals and humans. The company serves customers worldwide. ScarX Therapeutics Inc. was founded in 2012 and is based in Toronto, Canada.

MaRS Centre

West Tower

661 University Ave

Suite 465

Toronto, ON M5G 1M1

Canada

Founded in 2012

Phone:

647-258-4493

Key Executives for ScarX Therapeutics Inc.

Chief Executive Officer, President and Chief Operating Officer
Executive Chairman
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

ScarX Therapeutics Inc. Key Developments

ScarX Therapeutics Announces Approval for Trial of First Clinically-Promising Scar Reduction Cream

ScarX Therapeutics Inc. has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a topical treatment developed to significantly reduce surgical scarring. Applied immediately after surgical wound closure, SCX-001 reduces the amount of scar tissue that develops during the body's natural healing process. The 24-subject Phase I clinical trial will be conducted at the University of Alberta, and led by Principal Investigator Dr. Edward (Ted) Tredget. Dr. Tredget, a authority on burn injury and scarring, is Director of the Firefighters' Burn Treatment Unit and Wound Healing Research Laboratory at the University of Alberta's Faculty of Medicine & Dentistry, and President of the American Burn Association. Study enrolment is expected to begin in October, 2016.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 31, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ScarX Therapeutics Inc., please visit www.scarxtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.